Faculty of Pharmaceutical Medicine

Faculty of Pharmaceutical Medicine
Name	Faculty of Pharmaceutical Medicine
Formation	1976
Type	Professional body
Headquarters	United Kingdom
Region served	International
Parent organization	Royal College of Physicians

Contents

Faculty of Pharmaceutical Medicine The Faculty of Pharmaceutical Medicine is a professional body specializing in the discipline of pharmaceutical medicine and clinical development, formed to advance standards in drug development, regulatory affairs, pharmacovigilance and clinical trials. It interacts with organisations such as the Royal College of Physicians, General Medical Council, National Institute for Health and Care Excellence, European Medicines Agency and industry stakeholders including GlaxoSmithKline, AstraZeneca, Pfizer, Novartis to shape policy, education and practice. The Faculty provides qualifications, guidance and professional development aligned with regulators like the Medicines and Healthcare products Regulatory Agency and collaborates with academic institutions such as University College London, University of Oxford and King's College London.

History

The Faculty was established in 1976 within the Royal College of Physicians amid advances linked to drug development programmes at companies like Roche, Eli Lilly and Company, Merck & Co. and public initiatives such as the World Health Organization clinical research networks. Early influences included regulatory reforms following events connected with thalidomide and legislative changes in the United Kingdom and European Union medicines frameworks, with professional leaders from institutions such as St Bartholomew's Hospital, Guy's Hospital, Addenbrooke's Hospital and Royal Free Hospital contributing. Over time the Faculty engaged with international meetings like the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and collaborated with bodies including the British Pharmacological Society and Academy of Medical Sciences to expand curricula, standards and examinations.

Governance is conducted through an elected board and officers drawn from senior clinicians and industry leaders affiliated with bodies such as the Royal College of Physicians, Chartered Institute of Personnel and Development, Association of the British Pharmaceutical Industry, European Federation of Pharmaceutical Industries and Associations and academic chairs at Imperial College London. Committees cover education, assessment, ethics, and standards with liaisons to the General Medical Council, Health Research Authority, Clinical Trials Unit networks and specialist societies including the British Medical Association and Royal Society of Medicine. The Faculty's constitution and strategic plans reference collaborations with funders and policy organisations like the Wellcome Trust, Medical Research Council and National Institute for Health Research.

Membership categories include fellows, members, associates and affiliates with entrants often holding posts in hospitals, industry, regulators or universities such as University of Cambridge, Queen Mary University of London, University of Edinburgh and University of Manchester. Training programmes align with competency frameworks endorsed by the General Medical Council and are delivered through postgraduate centres, clinical trial units and pharmaceutical companies including Bristol Myers Squibb, Sanofi, Takeda and contract research organisations such as Quintiles and Parexel. Trainees undertake supervised placements in clinical research settings at institutions like Royal Marsden Hospital, Christie Hospital, Leeds Teaching Hospitals NHS Trust and receive mentorship from specialists affiliated with societies such as the European Society for Medical Oncology and International Society for Pharmacoeconomics and Outcomes Research.

The Faculty administers written and oral examinations culminating in a diploma and membership grades recognised by regulators including the General Medical Council and referenced by employers like NHS England, Department of Health and Social Care, European Medicines Agency and multinational pharmaceutical companies. Assessment formats incorporate multiple choice questions, structured oral examinations and workplace-based assessments used by postgraduate bodies such as the Royal College of Physicians, Royal College of Surgeons, Faculty of Occupational Medicine and align with standards from the International Council for Harmonisation. Certificates and diplomas are referenced by academic partners including London School of Hygiene & Tropical Medicine and credentialing bodies such as the UK Foundation Programme and specialist registries.

The Faculty issues professional guidance on Good Clinical Practice, pharmacovigilance, benefit–risk assessment and regulatory strategy, engaging with stakeholders including European Medicines Agency, Food and Drug Administration, World Health Organization, Health Technology Assessment International and patient organisations such as National Institute for Health and Care Excellence appraisal panels. It organises conferences, symposia and courses with speakers from institutions like Harvard Medical School, Mayo Clinic, Johns Hopkins University, University of California, San Francisco and industry leaders from Johnson & Johnson, Bayer and Amgen. Publications, position statements and training materials are produced in collaboration with journals and publishers such as The Lancet, British Medical Journal, Nature Medicine and Springer Nature.

The Faculty maintains international links with pharmaceutical and clinical research organisations including the International Federation of Pharmaceutical Manufacturers & Associations, International Conference on Harmonisation, European Federation of Pharmaceutical Industries and Associations, regional regulators such as the European Medicines Agency, MedDRA Maintenance and Support Services Organization contacts and academic partners in North America, Europe and Asia like Johns Hopkins University, Karolinska Institutet, Université Paris Cité and Peking University. Collaborative activities include joint training, reciprocal recognition, policy consultations and contributions to global initiatives by organisations such as the World Health Organization, Coalition for Epidemic Preparedness Innovations, Global Health Security Agenda and multinational research consortia involving Bill & Melinda Gates Foundation support.

Category:Medical associations based in the United Kingdom Category:Pharmaceutical industry